|
|
|
|
 |
| February 9, 2012 | ISSUE NUMBER 236 VOL 8 |
|
Drug Development
Is the U.S. Facing a Pharma Manufacturing Gap?
As FDA commissioner Margaret Hamburg pointed out last week in her testimony to the E&C Congressional Subcommittee on Health, the numbers prove the U.S. is indeed an important market for drug innovation. But as the agency confronts the mounting challenges of globalization, does this nation have a manufacturing disconnect? ...Read More
ePharma Summit
Less Proselytizing, More Results
Senior Editor Ben Comer reports from the floor of the digital marketing-focused conference in New York. And, as to be expected, the frustrations of developing social media strategies were rehashed yet again ...Read More
Pharm Exec's Brand of the Year
Abbott's Humira: Not First but Best to Market
Rich data on the clinical side, combined with flexible marketing and outreach to payers, have pushed Humira to the top ranks of powerhouse drugs. With five more years of exclusivity, patients are waiting for more ...Read More
Pharm Exec TV
Pfizer Proactive in Birth Control Pill Recall
Pfizer got ahead of the story with its recent recall of 28 lots of branded and generic birth control pills. Although the size of the recall was small, the company used it as an opportunity to show its concern for quality control ...Watch now
Ad Stars 2012
Call for Entries
It's that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We'd like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more information |
|
|
 // Dr. Barbara McNeil, Ridley Watts Professor and founding Head of the Department of Health Care Policy at Harvard Medical School, has been appointed to the Scientific Advisory Board of Humedica (Boston).
// Chairman and CEO of vaccine company Mymetrics, Jacques-Françios Martin, has been elected Chairman of the Board of Directors of biopharma firm Anergis (Epalinges, Switzerland). // Ogilvy CommonHealth Worldwide (Parsippany, N.J.) named Neil Contess president of its Consumer Care group and Iyiola Obayomi as senior director, consulting, of Ogilvy Healthworld in its New York office. //
Jürgen Frisch, MD, was appointed Chief Medical Officer of European Operations at Clinipace Worldwide (Zurich), where he will be responsible for providing leadership and direction to the medical and regulatory service groups.
|
|
|
 |
|
|
|
|
 |
|
 |
 |
|
 |
|
|
|
 |
 |
|
 |
To which of the following areas have you made changes to meet the challenge of demonstrating value?
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
